ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,477 Cr | ₹1,407 Cr | ₹1,343 Cr | ₹1,206 Cr | ₹1,203 Cr |
What is the latest Total Current Liabilities ratio of ABBOTT INDIA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹1,477 Cr |
| Mar2025 | ₹1,407 Cr |
| Mar2024 | ₹1,343 Cr |
| Mar2023 | ₹1,206 Cr |
| Mar2022 | ₹1,203 Cr |
How is Total Current Liabilities of ABBOTT INDIA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,477 Cr | 4.93 | |
| Mar2025 | ₹1,407 Cr | 4.80 | |
| Mar2024 | ₹1,343 Cr | 11.33 | |
| Mar2023 | ₹1,206 Cr | 0.24 | |
| Mar2022 | ₹1,203 Cr | - | |
Compare Total Current Liabilities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹57,819.4 Cr | 6.6% | 3.3% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 6.6% |
3.3% |
-16.3% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses